Delivery Order SPE2DB22D2206-SPE2DB25FJF75
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $23,847.20 to supply 180 tablets of INLYTA 1 mg, a pharmaceutical product for cancer treatment. This non-competitive, firm fixed-price delivery order was awarded on June 5, 2025, with a completion date of June 27, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $11,895.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of INLYTA 5 mg, a pharmaceutical product used in cancer treatment. This non-competitive delivery order, issued on September 4, 2025, will be fulfilled at the company's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. The award represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a $23,847.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for 180 tablets of Inlyta 1 mg, a pharmaceutical product for oncology treatment. This non-set-aside delivery order was competitively awarded on August 15, 2025, with an ultimate completion date of September 8, 2025. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Inlyta 5 mg tablets (60-count units) with a ceiling value of $11,895.72. This non-set-aside contract, awarded on July 21, 2025, utilizes firm fixed pricing and is scheduled for completion by August 11, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $11,895.72 delivery order to AmerisourceBergen Drug Corp for INLYTA 5 mg tablets (60-count units) on August 19, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $11.9K to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Inlyta 5 mg tablets (60-count units). The contract is firm fixed price with an ultimate completion date of October 2, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Inlyta 5 mg tablets (60-count units) valued at $23,791.44. This firm fixed-price delivery order, with an ultimate completion date of August 29, 2025, represents a competitive award with no set-aside designation. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $11.9K delivery order to AmerisourceBergen Drug Corp for 60 tablets of INLYTA 5 mg, a targeted cancer therapy medication. This firm fixed-price, non-set-aside contract was awarded on July 31, 2025, with completion required by August 21, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of INLYTA 5 mg tablets (60-count units) with a ceiling value of $11,895.72. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made through competitive procurement with no set-aside...
- The Defense Logistics Agency (DLA) awarded a $11,895.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of INLYTA 5 MG, a prescription medication used in cancer treatment. The order was competitively awarded without set-aside designation and is scheduled for completion by May 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and is one of the nation's largest pharmaceutical distributors, regularly fulfilling...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJF75Delivery Order
The Defense Logistics Agency awarded a $23,847.20 delivery order to AmerisourceBergen Drug Corp for 180 tablets of INLYTA 1 mg, a pharmaceutical product used in cancer treatment. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards with the DLA demonstrates its capability to meet competitive procurement requirements across multiple therapeutic domains, from specialty medications and brand-name drugs to vaccines and medical supplies. This delivery order for INLYTA exemplifies the company's role in supporting the Defense Health Agency and other government healthcare systems through flexible contract vehicles designed to ensure consistent pharmaceutical supply to military personnel and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.8k | 8/5/25 |